Mitigating Complications and Overcoming Barriers in Patients Receiving Factor Replacement Therapy

Download this short slideset from Clinical Care Options (CCO) on the management of newly diagnosed and relapsed light-chain (AL) amyloidosis

Ankit Kansagra, MD Shaji K. Kumar, MD Vaishali Sanchorawala, MD Released: January 19, 2022

Downloadable PDF summary transcript of expert answers to questions on hemophilia A management, from Clinical Care Options (CCO)

Miguel A. Escobar, MD Mark Reding, MD Guy A. Young, MD Released: January 18, 2022

Downloadable summary slideset from a live ASH 2021 satellite symposium on optimizing outcomes in hemophilia A with factor and nonfactor therapy from Clinical Care Options (CCO)

Miguel A. Escobar, MD
Program Director Mark Reding, MD Guy A. Young, MD Released: December 21, 2021

Efficacy and safety in the ATLAS-INH trial of fitusiran for hemophilia A or B with inhibitors presented at ASH 2021, as reported by Clinical Care Options (CCO)